Spiratisanin C exhibits significant antimicrobial activity, particularly against Gram-positive bacteria, making it a candidate for development in antibacterial therapies. It has shown potential in inhibiting biofilm formation, which is crucial in treating persistent infections associated with medical devices. Additionally, studies suggest anti-inflammatory properties, indicating possible use in inflammatory-related disorders. Its unique structure also supports research in drug design for targeting specific cellular pathways. Further exploration is ongoing for its role in anticancer applications due to observed cytotoxic effects on certain tumor cell lines.